Cetuximab, capecitabine, and oxaliplatin (Cet-CapOx) with concurrent radiotherapy (RT) in advanced rectal cancer (RC): Results of a phase I/II trial

被引：0
|
作者：
Arnold, D.
Hipp, M.
Liersch, T.
Dellas, K.
Koelbl, O.
Hohenberger, W.
Lordick, F.
Suelberg, H.
Sauer, R.
Roedel, C.
机构：
[1] Martin Luther Univ Halle Wittenberg, Halle, Germany
[2] Univ Hosp, Regensburg, Germany
[3] George August Univ, Gottingen, Germany
[4] Friedrich Alexander Univ, Erlangen, Germany
[5] Tech Univ, Munich, Germany
[6] WiSP Inst, Langenfeld, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4042
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Preoperative Treatment with Capecitabine, Cetuximab and Radiotherapy for Primary Locally Advanced Rectal Cancer - A Phase II Clinical Trial
    Eisterer, Wolfgang
    De Vries, Alexander
    Oefner, Dietmar
    Rabl, Hans
    Koplmueller, Renate
    Greil, Richard
    Tschmelitsch, Joeerg
    Schmid, Rainer
    Kapp, Karin
    Lukas, Peter
    Sedlmayer, Felix
    Hoefler, Gerald
    Gnant, Michael
    Thaler, Josef
    ANTICANCER RESEARCH, 2014, 34 (11) : 6767 - 6773
  • [32] Effect of pathohistologic complete remission (pCR) rate on the prediction of long-term prognosis following chemoradiotherapy (XRT) with cetuximab (Cet), capecitabine (CAP), and oxaliplatin (OX; Cet-CAPOX) in patients (pts) with locally advanced rectal cancer (LARC).
    Liersch, T.
    Weiss, C.
    Dellas, K.
    Hipp, M.
    Sauer, R.
    Roedel, C.
    Arnold, D.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [33] EXCITE: A PHASE II TRIAL OF PREOPERATIVE CETUXIMAB, IRINOTECAN AND CAPECITABINE PLUS RADIOTHERAPY (RT) IN MRI-DEFINED LOCALLY ADVANCED RECTAL CANCER (LARC)
    Gollins, S.
    Myint, A. S.
    Saunders, M. P.
    Susnerwala, S.
    Sebag-Montefiori, D.
    Beare, S.
    Williams, E.
    West, N.
    Jitlal, M.
    ANNALS OF ONCOLOGY, 2012, 23 : 206 - 207
  • [34] Cetuximab in combination with capecitabine, irinotecan and concurrent radiotherapy (CAPIRI-RT) for preoperative treatment of locally advanced rectal cancer
    Hofheinz, RD
    Horisberger, K
    Tiefenbacher, U
    Wenz, F
    von Gerstenberg, B
    Kähler, G
    Post, S
    Hochhaus, A
    Willeke, F
    ANNALS OF ONCOLOGY, 2006, 17
  • [35] Multi-institutional Phase II Trial of Induction Cetuximab Gemcitabine and Oxaliplatin, followed by Radiotherapy with Concurrent Capecitabine, and Cetuximab, for Locally Advanced Pancreatic Adenocarcinoma (LAPC)
    Crane, C. H.
    Varadhachary, G.
    Javle, M.
    Safran, H.
    Krishnan, S.
    Fleming, J.
    Das, P.
    Lee, J.
    Abbruzzese, J. L.
    Wolff, R. A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S102 - S102
  • [36] Multicenter phase II clinical trial of preoperative capecitabine with concurrent radiotherapy in patients with locally advanced rectal cancer
    Manuel de las Heras
    Fernando Arias
    Rosario del Moral-Avila
    Jaime Gómez-Millán
    Encarnación Jiménez
    Amadeo Wals
    Jose Luis Tisaire
    Ma Pino Alcantara
    Clinical and Translational Oncology, 2013, 15 : 294 - 299
  • [37] Multicenter phase II clinical trial of preoperative capecitabine with concurrent radiotherapy in patients with locally advanced rectal cancer
    de las Heras, Manuel
    Arias, Fernando
    del Moral-Avila, Rosario
    Gomez-Millan, Jaime
    Jimenez, Encarnacion
    Wals, Amadeo
    Luis Tisaire, Jose
    Pino Alcantara, Ma
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2013, 15 (04): : 294 - 299
  • [38] Bevacizumab, oxaliplatin, and capecitabine with radiation therapy in rectal cancer: Phase I trial results
    Czito, Brian G.
    Bendell, Johanna C.
    Willett, Christopher G.
    Morse, Michael A.
    Blobe, Gerard C.
    Tyler, Douglas S.
    Thomas, John
    Ludwig, Kirk A.
    Mantyh, Christopher R.
    Ashton, Jill
    Yu, Daohai
    Hurwitz, Herbert I.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 68 (02): : 472 - 478
  • [39] Preoperative chemoradiotherapy (QT-RT) with capecitabine and oxaliplatin (CAPOX) in patients with locally advanced rectal cancer.
    Sancho, Aintzane
    Marrodan, Ines
    Calvo, Begona
    Munoz, Alberto
    Manel Mane, Joan
    Carrera, Sergio
    Fuente, Natalia
    Azkona, Eider
    Arruti, Mikel
    Isabel Gutierrez, Eddy
    Ugalde, Irene
    Lopez-Vivanco, Guillermo
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [40] Prospective phase II trial of neoadjuvant chemo-radiotherapy with Oxaliplatin and Capecitabine in locally advanced rectal cancer (XELOXART)
    Umberto Ricardi
    Patrizia Racca
    Pierfrancesco Franco
    Fernando Munoz
    Laura Fanchini
    Nadia Rondi
    Vincenzo Dongiovanni
    Pietro Gabriele
    Paola Cassoni
    Libero Ciuffreda
    Mario Morino
    Andrea Riccardo Filippi
    Massimo Aglietta
    Oscar Bertetto
    Medical Oncology, 2013, 30
12345